Stephanie Cronin

Title: The Innovative Contributions of Stephanie Cronin

Introduction

Stephanie Cronin is an accomplished inventor based in Boston, MA. She has made significant strides in the field of organ transplantation through her innovative work in monitoring donor organ viability. Her contributions are particularly noteworthy for their potential impact on transplantation outcomes.

Latest Patents

Stephanie holds a patent for a groundbreaking technology titled "Donor organ viability monitoring using Raman spectroscopy." This technology includes a system and method for monitoring donor organ tissue using Raman spectroscopy. It enables real-time quantification of the mitochondrial redox state in tissue samples taken from organs intended for transplant. The compact device is based on resonance Raman spectroscopy, which can quantify the mitochondrial redox state in tissues using a Resonance Raman Reduced Mitochondrial Ratio. The mitochondrial redox state serves as a marker of tissue function, helping to distinguish between healthy and damaged tissue. Moreover, these measures may correlate with transplantation outcomes.

Career Highlights

Throughout her career, Stephanie has worked with notable organizations, including Pendar Technologies, LLC and The General Hospital Corporation. Her experience in these institutions has allowed her to refine her skills and contribute to advancements in medical technology.

Collaborations

Stephanie has collaborated with Daryoosh Vakhshoori, further enhancing her research and development efforts in the field of organ viability monitoring.

Conclusion

Stephanie Cronin's innovative work in donor organ viability monitoring exemplifies the intersection of technology and healthcare. Her contributions have the potential to significantly improve transplantation outcomes and advance the field of organ transplantation.